STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells

Oncogene
P GuhaS C Katz

Abstract

Immunosuppressive myeloid-derived suppressor cells (MDSC) subvert antitumor immunity and limit the efficacy of chimeric antigen receptor T cells (CAR-T). Previously, we reported that the GM-CSF/JAK2/STAT3 axis drives liver-associated MDSC (L-MDSC) proliferation and blockade of this axis rescued antitumor immunity. We extended these findings in our murine liver metastasis (LM) model, by treating tumor-bearing mice with STAT3 inhibitors (STATTIC or BBI608) to further our understanding of how STAT3 drives L-MDSC suppressive function. STAT3 inhibition caused significant reduction of tumor burden as well as L-MDSC frequencies due to decrease in pSTAT3 levels. L-MDSC isolated from STATTIC or BBI608-treated mice had significantly reduced suppressive function. STAT3 inhibition of L-MDSC was associated with enhanced antitumor activity of CAR-T. Further investigation demonstrated activation of apoptotic signaling pathways in L-MDSC following STAT3 inhibition as evidenced by an upregulation of the pro-apoptotic proteins Bax, cleaved caspase-3, and downregulation of the anti-apoptotic protein Bcl-2. Accordingly, there was also a decrease of pro-survival markers, pErk and pAkt, and an increase in pro-death marker, Fas, with activation of do...Continue Reading

References

Jan 1, 1997·Molecular and Cellular Biology·J M LenczowskiJ D Ashwell
Jan 1, 1997·Immunology Today·G KroemerS A Susin
Feb 1, 1997·Current Opinion in Genetics & Development·L Rao, E White
Aug 28, 1999·The Journal of Biological Chemistry·S C HsuM Z Lai
May 23, 2001·Leukemia·P P RuvoloW S May
Jul 23, 2002·Trends in Immunology·John A Hamilton
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roland LangPeter J Murray
Dec 31, 2002·Toxicology·J A Pietenpol, Z A Stewart
Feb 10, 2004·The Journal of Biological Chemistry·Shyra J GardaiPeter M Henson
Feb 18, 2004·Nature Reviews. Cancer·Hua Yu, Richard Jove
Nov 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Neha ParikhApurva Sarin
Dec 16, 2004·Medicinal Research Reviews·Martin Scholz, Jindrich Cinatl
Jul 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Steven C KatzRonald P DeMatteo
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eiji SuzukiSteven M Albelda
Dec 27, 2005·Current Drug Targets. Immune, Endocrine and Metabolic Disorders·Ilka Wittig, Bernd Groner
May 12, 2006·Nature·John L LangowskiMartin Oft
Nov 23, 2006·Chemistry & Biology·Jochen SchustThorsten Berg
May 8, 2007·Cancer Research·Pratima SinhaSuzanne Ostrand-Rosenberg
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Sep 9, 2008·The Journal of Clinical Investigation·Maciej KujawskiHua Yu
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Mar 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yongliang ZhangXuetao Cao
Jul 2, 2009·Annals of Surgical Oncology·Steven C KatzRonald P DeMatteo
Dec 17, 2010·World Journal of Gastrointestinal Oncology·Kebin Liu
Dec 29, 2010·Cell Research·Guobin He, Michael Karin
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Masahisa JinushiHideaki Tahara
Feb 22, 2012·Nature Reviews. Immunology·Onur Boyman, Jonathan Sprent

❮ Previous
Next ❯

Citations

Sep 5, 2019·Cancers·Cédric Rébé, François Ghiringhelli
Jul 7, 2020·Frontiers in Immunology·Alba Rodriguez-GarciaSonia Guedan
Jun 4, 2020·Cellular Oncology (Dordrecht)·Łukasz ZadkaPiotr Dzięgiel
Sep 26, 2020·Molecular Cancer·Sailan ZouXianghui Fu
Jul 16, 2020·Cancers·Eline JanssenDaniele V F Tauriello
Sep 19, 2020·Cancers·Yufei WangGuangwei Liu
Aug 28, 2020·Journal for Immunotherapy of Cancer·Steven C KatzRichard P Junghans
Jan 14, 2021·International Journal of Molecular Sciences·Manlio Tolomeo, Antonio Cascio
Jan 20, 2021·Journal of Bioenergetics and Biomembranes·Yang SunJianming Wei
Jun 12, 2020·Cancer Letters·Rui HuJian Zhang
Mar 3, 2021·Cellular Immunology·Jessica K Mandula, Paulo C Rodriguez
Mar 28, 2021·Cancer Communications·Cheng CuiLi Fu
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Xiangru HuangLingyong Jiang
May 12, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Jingshan CaiShengjun Wang
Sep 17, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Rafaela Nasser VeigaDaniela Fiori Gradia
Oct 9, 2021·Signal Transduction and Targeted Therapy·Kai LiYongsheng Wang
Jul 10, 2021·Recent Patents on Anti-cancer Drug Discovery·Junhe ZhangLinlin Shan
Oct 13, 2021·Cellular and Molecular Life Sciences : CMLS·Zhiguo LingYueqi Chen
Jan 29, 2022·International Journal of Immunopathology and Pharmacology·Qianqian HeChao Ding

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
flow cytometry
biopsy
protein assay

Clinical Trials Mentioned

NCT02178956
NCT02416466

Software Mentioned

ImageJ
STATTIC
FlowJo
GraphPad Prism

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis